X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (24) 24
humans (22) 22
oncology (18) 18
female (17) 17
middle aged (13) 13
breast cancer (12) 12
aged (11) 11
adult (10) 10
cancer (10) 10
health aspects (8) 8
breast neoplasms - drug therapy (7) 7
prognosis (7) 7
breast neoplasms - genetics (6) 6
breast neoplasms - pathology (6) 6
male (6) 6
aged, 80 and over (5) 5
analysis (5) 5
medicine & public health (5) 5
genes (4) 4
genetic testing (4) 4
genetics (4) 4
genomics (4) 4
neoplasm staging (4) 4
research (4) 4
risk (4) 4
tamoxifen (4) 4
abridged index medicus (3) 3
adjuvant treatment (3) 3
breast neoplasms - diagnosis (3) 3
cancer patients (3) 3
cancer research (3) 3
chemotherapy (3) 3
decision making (3) 3
diagnosis (3) 3
follow-up studies (3) 3
genetic counseling (3) 3
genetic predisposition to disease (3) 3
genome (3) 3
medicine (3) 3
multivariate analysis (3) 3
mutation (3) 3
prevention (3) 3
receptors, estrogen - metabolism (3) 3
retrospective studies (3) 3
risk assessment (3) 3
skin and connective tissue diseases (3) 3
surveys and questionnaires (3) 3
therapy (3) 3
treatment outcome (3) 3
trial (3) 3
women (3) 3
acmg recommendations (2) 2
adjuvant trastuzumab (2) 2
age (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic agents, hormonal - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
brca2 (2) 2
breast (2) 2
breast neoplasms - epidemiology (2) 2
breast neoplasms - metabolism (2) 2
carcinoma (2) 2
care and treatment (2) 2
cell line, tumor (2) 2
cohort studies (2) 2
combined modality therapy (2) 2
cost of illness (2) 2
early detection of cancer - methods (2) 2
epirubicin (2) 2
estrogen (2) 2
exemestane (2) 2
gene expression profiling - methods (2) 2
gene-expression (2) 2
genetic aspects (2) 2
genetic screening (2) 2
genetic testing - trends (2) 2
health knowledge, attitudes, practice (2) 2
health surveys (2) 2
homology (2) 2
incidental findings (2) 2
lynch syndrome (2) 2
medical colleges (2) 2
neoadjuvant therapy (2) 2
neoplasm recurrence, local - drug therapy (2) 2
neoplasm recurrence, local - genetics (2) 2
neoplasms - economics (2) 2
neoplasms - genetics (2) 2
neoplasms - psychology (2) 2
open-label (2) 2
personalized medicine (2) 2
physicians (2) 2
postmenopausal women (2) 2
prospective studies (2) 2
questionnaire (2) 2
regression analysis (2) 2
return (2) 2
review (2) 2
risk factors (2) 2
surgery (2) 2
surgical oncology (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Oncology Practice, ISSN 1554-7477, 07/2010, Volume 6, Issue 4, pp. 188 - 192
Patient-physician communication about cost when making treatment decisions has been promoted as a potential solution to the rising cost of oncologic care and... 
Journal Article
Cancer, ISSN 0008-543X, 11/2017, Volume 123, Issue 22, pp. 4363 - 4371
Journal Article
Journal of Oncology Practice, ISSN 1554-7477, 07/2012, Volume 8, Issue 4, pp. e50 - e58
Recent publications have promoted physician-patient communication on cost as a means of decreasing overall spending and minimizing patients' financial burden... 
Decision Making | Drug Costs | Neoplasms - economics | Medicare | United States | Humans | Middle Aged | Cost of Illness | Male | Physician-Patient Relations | Health Knowledge, Attitudes, Practice | Neoplasms - drug therapy | Young Adult | Health Care Costs | Medical Oncology - economics | Aged, 80 and over | Adult | Female | Surveys and Questionnaires | Aged | Medicaid | Insurance, Health
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2019, Volume 37, Issue 33, pp. 3152 - 3165
PURPOSE To update the ASCO guideline on pharmacologic interventions for breast cancer risk reduction and provide guidance on clinical issues that arise when... 
Journal Article
Current Breast Cancer Reports, ISSN 1943-4588, 6/2013, Volume 5, Issue 2, pp. 125 - 133
Journal Article
Journal of Oncology Practice, ISSN 1554-7477, 09/2014, Volume 10, Issue 5, pp. 332 - 338
Little is known about the relationship between the financial burden of cancer and the physical and emotional health of cancer survivors. We examined the... 
Multivariate Analysis | Neoplasms - economics | United States | Humans | Middle Aged | Survivors | Cost of Illness | Male | Antineoplastic Agents - therapeutic use | Neoplasms - psychology | Antineoplastic Agents - economics | Regression Analysis | Health Surveys | Quality of Life | Female | Aged
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 6/2018, Volume 169, Issue 2, pp. 333 - 340
The purpose of this two-cohort Phase II trial was to estimate the pathologic complete response (pCR: ypT0/is ypN0) rate when trastuzumab plus pertuzumab are... 
Neoadjuvant therapy | HER-2-positive | Medicine & Public Health | Pertuzumab | Pathological complete response | Oncology | Breast cancer | Trastuzumab | MULTICENTER | OPEN-LABEL | COMBINATION | PLUS TRASTUZUMAB | CHEMOTHERAPY | ADJUVANT TRASTUZUMAB | LAPATINIB | THERAPY | ONCOLOGY | CLINICAL-TRIALS | CONCURRENT | Cyclophosphamide - administration & dosage | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Epirubicin - administration & dosage | Cyclophosphamide - adverse effects | Drug-Related Side Effects and Adverse Reactions - pathology | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Adult | Female | Paclitaxel - administration & dosage | Taxoids - adverse effects | Breast Neoplasms - epidemiology | Antibodies, Monoclonal, Humanized - adverse effects | Paclitaxel - adverse effects | Trastuzumab - adverse effects | Trastuzumab - administration & dosage | Breast Neoplasms - drug therapy | Taxoids - administration & dosage | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Neoadjuvant Therapy - adverse effects | Bridged-Ring Compounds - adverse effects | Bridged-Ring Compounds - administration & dosage | Drug-Related Side Effects and Adverse Reactions - classification | Epirubicin - adverse effects | Anthracyclines | Cyclophosphamide | Analysis | Adjuvant treatment | Clinical trials | Product development | Health aspects | Cancer
Journal Article
Journal Article
Journal Article
Yale Journal of Biology and Medicine, ISSN 0044-0086, 06/2015, Volume 88, Issue 2, p. 181
Journal Article